Location History:
- Tokyo, JP (1999)
- Tokushima, JP (2010 - 2013)
Company Filing History:
2 out of 846 
1 out of 622 Years Active: 1999-2013
Title: Koji Suematsu: Innovator in Drug Safety
Introduction
Koji Suematsu is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of drug safety, particularly in assessing the risk of drug-induced granulocytopenia. With a total of 3 patents, his work has the potential to impact patient care and treatment protocols.
Latest Patents
One of his latest patents is a method for judging the risk of drug-induced granulocytopenia. This innovative approach provides means for determining the presence of this risk in humans. The method includes detecting a polymorphism of the human insulin receptor substrate-2 gene in a subject. By using this genetic polymorphism as an index, the presence of the risk of drug-induced granulocytopenia can be assessed effectively.
Career Highlights
Throughout his career, Koji Suematsu has worked with prominent companies such as Otsuka Pharmaceutical Company, Limited and Mitsubishi Paper Mills Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Koji has collaborated with notable coworkers, including Koichi Hasegawa and Haruhiko Ikeda. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Koji Suematsu is a distinguished inventor whose work in drug safety is paving the way for improved patient outcomes. His innovative methods and collaborations highlight the importance of genetic research in assessing drug risks.